Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma

DANIELA VAISMAN; JACOB PE'ER; M. A.Y.A. EIGER-MOSCOVICH; MICHAL LOTEM; SHARON MERIMS; SHAHAR FRENKEL

doi:10.1016/j.ajo.2026.04.026

Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma

DANIELA VAISMAN
, JACOB PE'ER
, M. A.Y.A. EIGER-MOSCOVICH
, MICHAL LOTEM
, SHARON MERIMS
, SHAHAR FRENKEL^*

^*Corresponding author for this work

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	355
Number of pages	1
Journal	American Journal of Ophthalmology
Volume	289
DOIs	https://doi.org/10.1016/j.ajo.2026.04.026
State	Published - Sep 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ajo.2026.04.026

Cite this

VAISMAN, DANIELA., PE'ER, JACOB., EIGER-MOSCOVICH, M. A. Y. A., LOTEM, MICHAL., MERIMS, SHARON., & FRENKEL, SHAHAR. (2026). Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma. American Journal of Ophthalmology, 289, 355. https://doi.org/10.1016/j.ajo.2026.04.026

@article{0546834c3b9947698ce63d8bf80ef694,

title = "Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma",

author = "DANIELA VAISMAN and JACOB PE'ER and EIGER-MOSCOVICH, \{M. A.Y.A.\} and MICHAL LOTEM and SHARON MERIMS and SHAHAR FRENKEL",

year = "2026",

month = sep,

doi = "10.1016/j.ajo.2026.04.026",

language = "אנגלית",

volume = "289",

pages = "355",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier Inc.",

}

VAISMAN, DANIELA, PE'ER, JACOB, EIGER-MOSCOVICH, MAYA, LOTEM, MICHAL, MERIMS, SHARON & FRENKEL, SHAHAR 2026, 'Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma', American Journal of Ophthalmology, vol. 289, pp. 355. https://doi.org/10.1016/j.ajo.2026.04.026

Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma. / VAISMAN, DANIELA; PE'ER, JACOB; EIGER-MOSCOVICH, M. A.Y.A. et al.
In: American Journal of Ophthalmology, Vol. 289, 09.2026, p. 355.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Reply to Comment on

T2 - Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma

AU - VAISMAN, DANIELA

AU - PE'ER, JACOB

AU - EIGER-MOSCOVICH, M. A.Y.A.

AU - LOTEM, MICHAL

AU - MERIMS, SHARON

AU - FRENKEL, SHAHAR

PY - 2026/9

Y1 - 2026/9

UR - https://www.scopus.com/pages/publications/105046476020

U2 - 10.1016/j.ajo.2026.04.026

DO - 10.1016/j.ajo.2026.04.026

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 42114633

AN - SCOPUS:105046476020

SN - 0002-9394

VL - 289

SP - 355

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

ER -

Reply to Comment on: Interferon alpha-2a as treatment for primary acquired melanosis with atypia and for primary acquired melanosis with atypia surrounding conjunctival melanoma

UN SDGs

Access to Document

Other files and links

Cite this